Kopran logo

Kopran share news, announcements and annual reports

NSE: KOPRANBSE: 524280Pharmaceuticals & BiotechnologySmall Cap

Kopran Limited · Face value ₹10 · Listed Mar 1993 on BSE, Jun 1999 on NSE
Last close ₹252.00down ₹0.45 (0.18%)BSE ₹251.40

Share price at the NSE close on 29 Oct 2026. Previous close ₹252.45.

29 Oct: open ₹253.70, high ₹256.15, low ₹245.35

52-week range of traded prices to 29 Oct 2026
₹107.00Low, 30 Mar 2026₹295.83High, 30 Sep 2026
Market cap
₹1,218 Cr1,663rd largest listed
P/E
48.75
P/B
2.30
Dividend yield
1.19%
ROE
4.8%
ROCE
6.2%
Debt to equity
0.29
Volume, NSE
2,09,65543.5% delivered

Kopran disputes and clarifications

18 filed, newest first.

  1. Sep 2026

  2. Apr 2026

  3. Mar 2025

    • 10 Mar · Legal

      Exchange has sought clarification from Kopran Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. The response of the Company is awaited.
  4. Jun 2023

    • 5 Jun · Legal

      Clarification by Kopran Limited Significant price movement has been observed in Kopran Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Kopran Limited has vide its letter inter-alia stated,
  5. Apr 2023

  6. Mar 2023

  7. Aug 2021

  8. May 2021

  9. Sep 2020

  10. Apr 2020

    • 3 Apr · Legal

      Clarification by Kopran Limited Significant price movement has been observed in Kopran Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Kopran Limited has vide its letter inter-alia stated, Dear Sir,This is with reference to your email NSE/CM/Surveillance/9193 dated 31st March, 2020 relating to the spurt in price movement on the exchanges. In this regard, we would like to bring to your kind attention that the Company has made all the necessary disclosures in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time and has not withheld any material information/event which in our opinion would have a bearing on the price/volume behavior on our scrip. The spurt in volume of our scrip /increase in the share price is purely market driven. The Company has been regularly sharing all information/announcements with the stock Exchange that have a bearing on the price/volume behavior on the scrip. We have been strictly following all the listing norms for disclosures, insider trading with the stock exchanges and there is no pending compliance on our part. Kindly take the same on record. RegardsSunil SodhaniCompany Secretary & Compliance OfficerKopran Ltd.1076, Parijat House, Dr. E. Moses Road, Worli, Mumbai - 400 018.Tel: 022 - 4366 1111 Extn 251;Fax: 022 - 2495 0363
  11. Mar 2020

    • 31 Mar · Legal

      Significant movement in price has been observed in Kopran Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
  12. Sep 2016

  13. Jul 2015